StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Protagenic Therapeutics, Inc.new's operating cash flow for the twelve months ending Dec 31, 2024 was -$4.22M. For fiscal 2024 it was -$4.22M. The highest annual figure on record is -$487.99K in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$4.22M–
FY2023Dec 31, 2023-$3.70M–
FY2022Dec 31, 2022-$1.99M–
FY2021Dec 31, 2021-$2.80M–
FY2020Dec 31, 2020-$1.35M–
FY2019Dec 31, 2019-$487.99K–
FY2018Dec 31, 2018-$1.07M–
FY2017Dec 31, 2017-$1.38M–
FY2016Dec 31, 2016-$1.14M–
FY2014Jun 30, 2014-$790.00K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ1 2026Jun 30, 2026-$944.30K–
Q4 FY2024CQ4 2024Dec 31, 2024-$819.79K–
Q3 FY2024CQ3 2024Sep 30, 2024-$185.66K–
Q2 FY2024CQ2 2024Jun 30, 2024-$246.43K–
Q1 FY2024CQ1 2024Mar 31, 2024-$1.66M–
Q4 FY2023CQ4 2023Dec 31, 2023-$1.14M–
Q3 FY2023CQ3 2023Sep 30, 2023-$655.77K–
Q2 FY2023CQ2 2023Jun 30, 2023-$1.53M–
Q1 FY2023CQ1 2023Mar 31, 2023-$371.83K–
Q4 FY2022CQ4 2022Dec 31, 2022-$180.94K–
Q3 FY2022CQ3 2022Sep 30, 2022-$535.23K–
Q2 FY2022CQ2 2022Jun 30, 2022-$847.08K–
Q1 FY2022CQ1 2022Mar 31, 2022-$430.57K–
Q4 FY2021CQ4 2021Dec 31, 2021-$405.09K–
Q3 FY2021CQ3 2021Sep 30, 2021-$1.08M–
Q2 FY2021CQ2 2021Jun 30, 2021-$710.38K–
Q1 FY2021CQ1 2021Mar 31, 2021-$607.71K–
Q4 FY2020CQ4 2020Dec 31, 2020-$320.87K–
Q3 FY2020CQ3 2020Sep 30, 2020-$517.81K–
Q2 FY2020CQ2 2020Jun 30, 2020-$145.69K–
Q1 FY2020CQ1 2020Mar 31, 2020-$364.41K–
Q4 FY2019CQ4 2019Dec 31, 2019-$149.42K–
Q3 FY2019CQ3 2019Sep 30, 2019-$61.76K–
Q2 FY2019CQ2 2019Jun 30, 2019-$80.79K–
Q1 FY2019CQ1 2019Mar 31, 2019-$196.02K–
Q4 FY2018CQ4 2018Dec 31, 2018-$307.79K–
Q3 FY2018CQ3 2018Sep 30, 2018-$159.63K–
Q2 FY2018CQ2 2018Jun 30, 2018-$344.76K–
Q1 FY2018CQ1 2018Mar 31, 2018-$259.01K–
Q4 FY2017CQ4 2017Dec 31, 2017-$417.02K–
Q3 FY2017CQ3 2017Sep 30, 2017-$358.80K–
Q2 FY2017CQ2 2017Jun 30, 2017-$246.88K–
Q1 FY2017CQ1 2017Mar 31, 2017-$357.40K–
Q4 FY2016CQ4 2016Dec 31, 2016-$341.81K–
Q3 FY2016CQ3 2016Sep 30, 2016-$296.07K–
Q2 FY2016CQ2 2016Jun 30, 2016-$445.05K–
Q1 FY2016CQ1 2016Mar 31, 2016-$57.39K–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?